Angiotensin II upregulates the expression of placental growth factor in human vascular endothelial cells and smooth muscle cells
Open Access
- 26 May 2010
- journal article
- Published by Springer Science and Business Media LLC in BMC Cell Biology
- Vol. 11 (1), 1-9
- https://doi.org/10.1186/1471-2121-11-36
Abstract
Background: Atherosclerosis is now recognized as a chronic inflammatory disease. Angiotensin II (Ang II) is a critical factor in inflammatory responses, which promotes the pathogenesis of atherosclerosis. Placental growth factor (PlGF) is a member of the vascular endothelial growth factor (VEGF) family cytokines and is associated with inflammatory progress of atherosclerosis. However, the potential link between PlGF and Ang II has not been investigated. In the current study, whether Ang II could regulate PlGF expression, and the effect of PlGF on cell proliferation, was investigated in human vascular endothelial cells (VECs) and smooth muscle cells (VSMCs). Results: In growth-arrested human VECs and VSMCs, Ang II induced PlGF mRNA expression after 4 hour treatment, and peaked at 24 hours. 10-6 mol/L Ang II increased PlGF protein production after 8 hour treatment, and peaked at 24 hours. Stimulation with Ang II also induced mRNA expression of VEGF receptor-1 and -2(VEGFR-1 and -2) in these cells. The Ang II type I receptor (AT1R) antagonist blocked Ang II-induced PlGF gene expression and protein production. Several intracellular signals elicited by Ang II were involved in PlGF synthesis, including activation of protein kinase C, extracellular signal-regulated kinase 1/2 (ERK1/2) and PI3-kinase. A neutralizing antibody against PlGF partially inhibited the Ang II-induced proliferation of VECs and VSMCs. However, this antibody showed little effect on the basal proliferation in these cells, whereas blocking antibody of VEGF could suppress both basal and Ang II-induced proliferation in VECs and VSMCs. Conclusion: Our results showed for the first time that Ang II could induce the gene expression and protein production of PlGF in VECs and VSMCs, which might play an important role in the pathogenesis of vascular inflammation and atherosclerosis.Keywords
This publication has 44 references indexed in Scilit:
- Hypertrophic response to angiotensin II is mediated by protein kinase D-extracellular signal-regulated kinase 5 pathway in human aortic smooth muscle cellsBiochemical and Biophysical Research Communications, 2009
- Angiotensin II Stimulates KLF5 Phosphorylation and its Interaction with c-Jun Leading to Suppression of p21 Expression in Vascular Smooth Muscle CellsThe Journal of Biochemistry, 2009
- Birth weight and characteristics of endothelial and smooth muscle cell cultures from human umbilical cord vesselsJournal of Translational Medicine, 2009
- ANGIOTENSIN II-INDUCED GROWTH OF VASCULAR SMOOTH MUSCLE CELLS IS ASSOCIATED WITH MODULATION OF CELL SURFACE AREA AND PLATELET-DERIVED GROWTH FACTOR RECEPTOR EXPRESSIONClinical and Experimental Pharmacology and Physiology, 2007
- Role of Placenta Growth Factor in Cardiovascular HealthTrends in Cardiovascular Medicine, 2002
- Inflammation and AtherosclerosisCell Metabolism, 2002
- Role of angiotensin II type 1 receptor in the regulation of cellular adhesion molecules in atherosclerosisAmerican Heart Journal, 2001
- Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditionsNature Medicine, 2001
- Angiotensin II and atherosclerosisThe American Journal of Cardiology, 2001
- Matrix-Dependent Gene Expression of Egr-1 and PDGF A Regulate Angiotensin II–Induced Proliferation in Human Vascular Smooth Muscle CellsHypertension, 1999